Merck’s At-Home Antiviral COVID-19 Pill Gets US Authorization
The US on Thursday authorized Merck & Co’s antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar but more effective treatment from Pfizer Inc.
Merck’s drug, molnupiravir,…
Read More...
Read More...